Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

ANRO Stock Latest News

The FlyAlto Neuroscience highlights study results guiding ALTO-207 development

29d ago

ANRO

PremiumRatings

Optimistic Buy Rating for Alto Neuroscience Amid Promising ALTO-203 Developments and Strategic Opportunities

1M ago

ANRO

PremiumRatings

Promising Phase 2 Results for ALTO-203 in Treating Anhedonia-MDD Justify Buy Rating

1M ago

ANRO

PremiumThe Fly

Alto Neuroscience identifies biomarker, reports ALTO-203 pharmacodynamic results

1M ago

ANRO

PremiumCompany Announcements

Alto Neuroscience Reports Positive Phase 2 Trial Results

1M ago

ANRO

PremiumRatingsPromising Future for Alto Neuroscience: Strategic Acquisition and Strong Financial Position Drive Buy Rating

2M ago

ANRO

Premium

Ratings

Buy Rating for Alto Neuroscience Driven by Strategic Acquisitions and Promising Pipeline Developments

2M ago

ANRO

Premium

Ratings

Alto Neuroscience’s Strategic Acquisition and Promising Pipeline Boost Buy Rating

2M ago

ANRO

PremiumRatings

Strategic Acquisition and Promising Clinical Developments Drive Buy Rating for Alto Neuroscience, Inc.

2M ago

ANRO

PremiumCompany Announcements

Alto Neuroscience Acquires Assets from Chase Therapeutics

2M ago

ANRO

PremiumThe Fly

Alto Neuroscience acquires dopamine agonist combination candidate

2M ago

ANRO

PremiumRatings

Alto Neuroscience, Inc.: Promising Clinical Trials and Strong Financial Position Justify Buy Rating

2M ago

ANRO

PremiumCompany AnnouncementsAlto Neuroscience Advances Precision Psychiatry Pipeline

2M ago

ANRO

Premium

Ratings

Alto Neuroscience, Inc.: Buy Rating Affirmed on Strong Financial Outlook and Promising Clinical Trials

2M ago

ANRO

Premium

Ratings

Promising Future for Alto Neuroscience: Strong Pipeline and Financial Stability Drive Buy Rating

3M ago

ANRO

PremiumCompany Announcements

Alto Neuroscience Approves Key Proposals at Annual Meeting

3M ago

ANRO

PremiumRatings

Optimistic Outlook on Alto Neuroscience: Advancements in Precision Neuropsychiatry and Biomarker-Driven Treatments

3M ago

ANRO

PremiumRatings

Innovative Biomarker-Driven Strategy and Promising Pipeline Support Buy Rating for Alto Neuroscience

3M ago

ANRO

PremiumThe Fly

Alto Neuroscience presents new data at Society of Biological Psychiatry meeting

3M ago

ANRO

PremiumThe FlyAlto Neuroscience initiated with a Buy at H.C. Wainwright

4M ago

ANRO

Premium

Ratings

Buy Rating Reaffirmed for Alto Neuroscience, Inc. Amid Promising Pipeline and Upcoming Data Readouts

4M ago

ANRO

Premium

Ratings

Promising Clinical Trials and Strong Financials Justify Buy Rating for Alto Neuroscience, Inc.

4M ago

ANRO

ANRO Stock Latest News

Trending

Indices

Stocks

ETFs